Our finding that MEK/ERK1/2 primarily mediates TGF-β-induced EV secretion, agrees with a report, not related to TGF-β, that implicated MEK/ERK1/2 signaling in EV production by MVBs in colorectal and renal cancer cells [13]. This evidence concerns the gene MAPK3 and renal carcinoma.